← FDA DRUG APPROVALS

FDA ANDA · ANDA201973

TRAMADOL HYDROCHLORIDE

Sponsor: IPCA LABS LTD

APPLICATION
ANDA201973
TYPE
ANDA
ORIGINAL APPROVAL
2012-11-16
LATEST ACTION
2026-06-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRAMADOL HYDROCHLORIDEDiscontinued
TRAMADOL HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

2026-06-18REMS · Supplement 14AP
2025-12-29Labeling · Supplement 13 · standardAP
2024-10-31REMS · Supplement 11AP
2023-12-15Labeling · Supplement 10 · standardAP
2023-09-12Labeling · Supplement 9 · standardAP
2023-01-17Labeling · Supplement 8 · standardAP
2023-01-17Labeling · Supplement 6 · standardAP
2023-01-17Labeling · Supplement 4 · standardAP
2023-01-17Labeling · Supplement 2 · standardAP
2023-01-17Labeling · Supplement 7 · standardAP
2023-01-17Labeling · Supplement 5 · standardAP
2023-01-17Labeling · Supplement 1 · standardAP
2018-09-18REMS · Supplement 3AP
2012-11-16Not Applicable · OriginalREMSAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →